Corient Private Wealth
DXCM icon

Corient Private Wealth’s DexCom DXCM Stock Holding History

Corient Private Wealth’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.01M Sell
126,752
-107,090
-46% -$7.46M 0.01% 694
2025
Q4 		$15.3M Buy
233,842
+197,556
+544% +$12.8M 0.01% 636
2025
Q3 		$2.44M Sell
36,286
-85,838
-70% -$6.79M ﹤0.01% 978
2025
Q2 		$10.7M Buy
122,124
+1,433
+1% +$112K 0.01% 517
2025
Q1 		$8.24M Sell
120,691
-6,688
-5% -$546K 0.01% 558
2024
Q4 		$9.91M Sell
127,379
-2,402
-2% -$178K 0.02% 517
2024
Q3 		$8.7M Sell
129,781
-20,530
-14% -$1.69M 0.01% 599
2024
Q2 		$17M Buy
150,311
+3,403
+2% +$430K 0.03% 418
2024
Q1 		$20.4M Sell
146,908
-16,205
-10% -$2.04M 0.04% 386
2023
Q4 		$20.2M Buy
163,113
+13,132
+9% +$1.34M 0.04% 384
2023
Q3 		$14.4M Sell
149,981
-4,909
-3% -$553K 0.03% 413
2023
Q2 		$19.9M Buy
154,890
+4,844
+3% +$586K 0.05% 341
2023
Q1 		$17.4M Buy
150,046
+4,550
+3% +$509K 0.05% 341
2022
Q4 		$16.5M Buy
+145,496
New +$16M 0.06% 294

Other funds holding DXCM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Corient Private Wealth's DXCM Position: Q1 2026 in Review

Corient Private Wealth reduced its DexCom (DXCM) stake by 46% in Q1 2026, selling an estimated $7.46M and leaving 126,752 shares worth $8.01M. The position accounts for 0.01% of the portfolio, ranked #694.

Corient Private Wealth first reported a position in DXCM in Q4 2022 and has held it in 14 quarters since. The position peaked at $20.4M in Q1 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Corient Private Wealth held 126,752 shares of DexCom worth $8.01M as of Q1 2026.
  • Corient Private Wealth sold 107,090 DexCom shares in Q1 2026, an estimated $7.46M.
  • DexCom made up 0.01% of Corient Private Wealth's portfolio in Q1 2026, its #694 holding.
  • Corient Private Wealth first reported a position in DexCom in Q4 2022 and has held it in 14 quarters since.
  • Corient Private Wealth's DexCom position peaked at $20.4M in Q1 2024.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.